Acconeer AB (ACCON)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 10.74 |
|---|---|
| 52-week range | 6.00 – 26.90 |
| Return, 1 month / 3 months | −10.6% / −34.4% |
| Return, 1 year / 3 years | +56.3% / −23.2% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 87.5% |
| Worst drawdown (1 year) | -57.2% |
| Average daily value traded | 2.13M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Acconeer is a Swedish technology company based in Lund that develops small radar sensors and the software that goes with them. Its sensors use pulsed coherent radar to detect presence, movement and distance, and they are supplied to manufacturers and developers who build them into consumer electronics, industrial equipment and other products. The company provides sensor modules, evaluation kits and supporting software so customers can integrate the technology into their own designs.
The shares are listed on the Nasdaq Stockholm in Sweden under the code ACCON, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Acconeer AB (ACCON) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 10.74 on 27 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 636 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 56.3% and over the last three months it fell 34.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.4% | ||
| From 52-week high | -56.9% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -34.4% | ||
| 6-month return | -26.1% | ||
| 12-month return, skipping the last month | 75.0% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 87.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.2% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.13M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.4% |
|---|---|
| 1 month | −10.6% |
| 3 months | −34.4% |
| 6 months | −26.1% |
| 1 year | +56.3% |
| 3 years | −23.2% |
| 5 years | −79.4% |
Signals
| 50-day / 200-day average | 13.08 / 14.02 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.60 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.